However, combining ACSL3 and ACSL4 staining did improve performance for distinguishing HCC from CCA (AUC 0.801; CI (0.762–0.89); sensitivity 80.1 %; specificity 77.1 % (Table 3)). The gene discussed is ACSL3; the disease is hepatocellular carcinoma.